SG Americas Securities LLC increased its stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 1,553.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 334,034 shares of the company's stock after purchasing an additional 313,826 shares during the quarter. SG Americas Securities LLC's holdings in Keurig Dr Pepper were worth $11,431,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the business. GAMMA Investing LLC boosted its holdings in shares of Keurig Dr Pepper by 23.2% in the 1st quarter. GAMMA Investing LLC now owns 9,963 shares of the company's stock valued at $341,000 after acquiring an additional 1,879 shares during the last quarter. Yousif Capital Management LLC lifted its position in shares of Keurig Dr Pepper by 4.5% during the first quarter. Yousif Capital Management LLC now owns 150,933 shares of the company's stock worth $5,165,000 after purchasing an additional 6,525 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Keurig Dr Pepper by 122.1% in the 1st quarter. Farther Finance Advisors LLC now owns 8,771 shares of the company's stock valued at $307,000 after acquiring an additional 4,822 shares during the last quarter. Park Avenue Securities LLC acquired a new stake in Keurig Dr Pepper during the 1st quarter worth $251,000. Finally, Barden Capital Management Inc. increased its position in Keurig Dr Pepper by 1.7% during the 1st quarter. Barden Capital Management Inc. now owns 40,530 shares of the company's stock worth $1,387,000 after purchasing an additional 694 shares during the period. 93.99% of the stock is owned by hedge funds and other institutional investors.
Keurig Dr Pepper Trading Down 0.2%
Shares of Keurig Dr Pepper stock traded down $0.06 on Friday, hitting $33.09. 4,241,731 shares of the company traded hands, compared to its average volume of 10,780,547. The stock's 50 day moving average price is $33.91 and its 200-day moving average price is $33.07. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper Inc. has a 52 week low of $30.12 and a 52 week high of $38.28. The company has a market cap of $44.94 billion, a PE ratio of 20.03, a PEG ratio of 2.42 and a beta of 0.48.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion during the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The business's quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.38 EPS. Equities research analysts predict that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.
Keurig Dr Pepper Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.23 per share. The ex-dividend date is Friday, June 27th. This represents a $0.92 annualized dividend and a yield of 2.78%. Keurig Dr Pepper's dividend payout ratio is currently 83.64%.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on the company. Wells Fargo & Company reiterated an "overweight" rating on shares of Keurig Dr Pepper in a report on Tuesday, February 25th. Barclays boosted their target price on Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $42.00 price objective on shares of Keurig Dr Pepper in a research note on Tuesday, April 22nd. Morgan Stanley upgraded shares of Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $38.00 to $40.00 in a research note on Tuesday, April 1st. Finally, UBS Group lifted their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $39.33.
Read Our Latest Report on KDP
Insiders Place Their Bets
In other news, VP Angela A. Stephens sold 14,500 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total value of $496,480.00. Following the transaction, the vice president now owns 62,411 shares in the company, valued at $2,136,952.64. This represents a 18.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $33.96, for a total value of $7,063,680.00. Following the sale, the director now directly owns 3,054,490 shares of the company's stock, valued at $103,730,480.40. The trade was a 6.38% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 698,500 shares of company stock valued at $23,591,400. 0.40% of the stock is owned by company insiders.
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report